HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Felice Brizzi Selected Research

Acute Coronary Syndrome

9/2021Percutaneous Coronary Intervention (PCI) Reprograms Circulating Extracellular Vesicles from ACS Patients Impairing Their Cardio-Protective Properties.
1/2021Extracellular vesicles from patients with Acute Coronary Syndrome impact on ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Felice Brizzi Research Topics

Disease

19Neoplasms (Cancer)
01/2023 - 03/2004
5Inflammation (Inflammations)
01/2023 - 08/2012
5Breast Neoplasms (Breast Cancer)
04/2017 - 01/2014
4Fibrosis (Cirrhosis)
10/2021 - 01/2018
4Type 2 Diabetes Mellitus (MODY)
01/2019 - 04/2010
3Neoplasm Metastasis (Metastasis)
01/2023 - 04/2017
2Infections
03/2023 - 09/2021
2Sepsis (Septicemia)
03/2023 - 09/2021
2Disease Progression
10/2022 - 12/2018
2Triple Negative Breast Neoplasms
08/2022 - 10/2020
2Carcinoma (Carcinomatosis)
08/2022 - 01/2014
2Acute Coronary Syndrome
09/2021 - 01/2021
2Pathologic Processes
10/2020 - 11/2016
2Ischemia
01/2020 - 01/2017
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2019 - 08/2004
2Diabetes Complications
04/2015 - 01/2015
1Unstable Angina
11/2023
1Myocardial Infarction
11/2023
1Proteinuria
10/2022
1Reperfusion Injury
09/2021
1Thrombotic Microangiopathies
04/2021
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
04/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2021
1Vasculitis (Vasculitides)
04/2021
1Ulcer
04/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Weight Loss (Weight Reduction)
01/2020
1Necrosis
01/2020
1Cicatrix (Scar)
10/2019
1Hepatocellular Carcinoma (Hepatoma)
06/2019
1Hyperglycemia
01/2019
1Lymphoma (Lymphomas)
12/2018
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2018
1Ovarian Neoplasms (Ovarian Cancer)
01/2018
1Heart Failure
12/2017
1Infarction (Infarctions)
12/2017
1Heart Diseases (Heart Disease)
12/2017
1Hypertension (High Blood Pressure)
09/2017
1Liver Diseases (Liver Disease)
01/2017
1Shock
01/2017
1Mitochondrial Diseases (Mitochondrial Disease)
01/2017
1Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy)
01/2017
1Melanoma (Melanoma, Malignant)
01/2016
1Glucose Intolerance
04/2015

Drug/Important Bio-Agent (IBA)

7MicroRNAs (MicroRNA)IBA
10/2022 - 08/2010
6Biomarkers (Surrogate Marker)IBA
10/2022 - 04/2013
6Interleukin-3 (Interleukin 3)IBA
10/2020 - 07/2002
5Proteins (Proteins, Gene)FDA Link
01/2023 - 07/2002
5GhrelinIBA
12/2017 - 04/2010
4CateninsIBA
10/2021 - 01/2018
3IntegrinsIBA
04/2017 - 08/2007
3erucylphosphocholineIBA
04/2010 - 05/2007
2Phenobarbital (Luminal)FDA Link
08/2022 - 01/2014
2salicylhydroxamic acid (SHAM)IBA
09/2021 - 01/2021
2Lipid Bilayers (Lipid Bilayer)IBA
08/2021 - 06/2021
2Therapeutic UsesIBA
04/2021 - 01/2019
2aristolochic acid I (aristolochic acid)IBA
01/2020 - 01/2018
2Streptozocin (Streptozotocin)FDA Link
01/2019 - 01/2019
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 08/2012
2CytokinesIBA
01/2018 - 02/2005
2Reactive Oxygen Species (Oxygen Radicals)IBA
09/2017 - 04/2015
2Stem Cell FactorIBA
01/2014 - 01/2014
1omega-Chloroacetophenone (Mace)IBA
11/2023
1CholesterolIBA
11/2023
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2023
1Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
01/2023
1SARS-CoV-2 spike proteinIBA
01/2023
1Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA
01/2023
1LipopolysaccharidesIBA
01/2023
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2023
1Metformin (Glucophage)FDA LinkGeneric
09/2021
1ThiazolidinedionesIBA
09/2021
1Insulin (Novolin)FDA Link
09/2021
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
04/2021
1Messenger RNA (mRNA)IBA
01/2021
1VimentinIBA
10/2020
1CreatinineIBA
01/2020
1Neuregulin-1 (Neuregulin 1)IBA
01/2020
1NitrogenIBA
01/2020
1Urea (Carbamide)FDA LinkGeneric
01/2020
1ResveratrolIBA
01/2019
1Sirtuin 1IBA
01/2019
1Complement System Proteins (Complement)IBA
12/2018
1Glycogen Synthase (Synthase I)IBA
01/2018
1PotassiumIBA
12/2017
1Endothelin-1 (Endothelin 1)IBA
12/2017
1Adrenergic Agents (Adrenergic Drugs)IBA
12/2017
1Peptides (Polypeptides)IBA
12/2017
1mitochondrial K(ATP) channelIBA
12/2017
1Adenosine Triphosphate (ATP)IBA
12/2017
1AntioxidantsIBA
09/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2017
1Focal Adhesion Protein-Tyrosine KinasesIBA
04/2017
1Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
01/2016

Therapy/Procedure

5Therapeutics
01/2022 - 12/2013
2Percutaneous Coronary Intervention
09/2021 - 01/2021
1Glycemic Control
09/2021
1Intravenous Injections
10/2020
1Hepatectomy
01/2017
1Liver Transplantation
01/2017